February 16, 2021Open Access

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India

Key points are not available for this paper at this time.

Clinical Trial Registry of India (CTRI No/2016/10/007399).

KI fragen

Bookmark

View Full Paper

Cite This Study

Jambulingam et al. (Tue,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper